Mitral transcatheter edge-to-edge repair (M-TEER) reduced cardiovascular death and heart failure (HF)-related hospitalizations with improved health status in patients with HF and moderate to severe functional mitral regurgitation (FMR), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
RESHAPE-HF2 trial shows M-TEER as effective treatment for functional mitral regurgitation
- Post author:
- Post published:September 1, 2024
- Post category:uncategorized